Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Moderna (MRNA) drops after announcing a $3.1 billion charge, partially due to Covid writedowns
November 2, 2023 6:58 AM EDTModerna (NASDAQ: MRNA) shares fell about 2% in pre-market Thursday trade after the pharma company said its third-quarter results were impacted by a $3.1 billion charge related to resizing and a tax valuation allowance.
It includes $1.3 billion for inventory write-downs related to excess and obsolete COVID-19... More
Moderna (MRNA) Reports Wide Q3 Loss on $3.1B Charge, as Revenues Beat
November 2, 2023 6:36 AM EDTModerna (NASDAQ: MRNA) reported Q3 EPS of ($9.53), which may not compare to the analyst estimate of ($1.90). Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.4 billion.
Company has significantly improved future cost of sales by resizing its manufacturing... More



